TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/15/2025
Back to search
Official data from USPTO
PANAMERICAN CONGRESS ON VASCULAR AND ENDOVASCULAR SURGERY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PANAMERICAN CONGRESS ON VASCULAR AND ENDOVASCULAR SURGERY
ST13
US500000076210942Class
35, 41
Filing
76210942
Registration
2684880
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
07/20/2025
Trademark type
Word
Nice classes
35, 41
Filing date
02/15/2001
Registration date
02/04/2003
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/30/2023
Last transaction
07/20/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
2000-01-00
First use in commerce
2000-01-00
Drawing code
1
Owner type
01
Owner location
Brooklyn, NY
Examiner
FRENCH, CURTIS
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Ascher, Enrico
Representatives
Peter Sloane Leason Ellis LLP
Technical classification
Nice Classes
Class 35Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
ORGANIZING AND MANAGING CONFERENCE FOR OTHERSCONFERENCES IN THE FIELD OF VASCULAR MEDICINE TO PROMOTE NEW MEDICAL IDEAS AND TRENDS TO PHYSICIANS
Class 41
EDUCATIONAL SERVICESCONDUCTING CONFERENCES IN THE FIELD OF VASCULAR MEDICINE TO PROMOTE NEW MEDICAL IDEAS AND TRENDS TO PHYSICIANS
Publications
History of USPTO decisions and trademark events.
39 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/15/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/15/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/03/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/30/2023
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
06/30/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/30/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/30/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
12/05/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/04/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/06/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/06/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/06/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
02/04/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/03/2011
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/25/2011
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
08/05/2009
PLGL
ASSIGNED TO PARALEGAL
07/30/2009
ES8R
TEAS SECTION 8 RECEIVED
07/27/2009
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/07/2009
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/07/2009
CFIT
CASE FILE IN TICRS
03/11/2008
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
02/04/2003
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
11/21/2002
IUAA
USE AMENDMENT ACCEPTED
11/18/2002
DOCK
ASSIGNED TO EXAMINER
10/18/2002
DOCK
ASSIGNED TO EXAMINER
10/08/2002
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
08/27/2002
IUAF
USE AMENDMENT FILED
08/08/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/08/2002
PAPER RECEIVED
08/08/2002
CNFR
FINAL REFUSAL MAILED
02/04/2002
DOCK
ASSIGNED TO EXAMINER
12/09/2001
DOCK
ASSIGNED TO EXAMINER
10/24/2001
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/20/2001
CNRT
NON-FINAL ACTION MAILED
06/26/2001
DOCK
ASSIGNED TO EXAMINER
06/13/2001
Continuous trademark protection
Get notified about every new filing that threatens PANAMERICAN CONGRESS ON VASCULAR AND ENDOVASCULAR SURGERY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.